We’ve now heard from multiple sources in our network that C Sixty, the battle-scarred start-up company developing fullerenes as therapeutic agents for neurodegenerative diseases, is on the receiving end of...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)